Médecine autochtone sud-africaine (muti) et innovation biopharmaceutique : connaître l'umhlonyane
Keywords:
Muti, Artemisia afra, South Africa, preclinical trial, biopharmaceutical innovation, ontologyAbstract
The medicinal plant umhlonyane or Artemisia afra
(Jaqu. Ex. Willd.) is currently under examination by the
preclinical trial in Cape Town, South Africa. The objective is
to determine its efficacy at the biomolecular level in order to
find a cure against the tuberculosis pandemic. In parallel, the
trial aims to recognize indigenous knowledge hinting at its
therapeutic potential. I thus aim to understand how scientists,
indigenous healer-diviners and herbalists collaborate and con
ciliate their respective approaches which distinguish them
selves in the ontologies they bring into being.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Julie Laplante
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to Anthropologica agree to release their articles under the Creative Commons Attribution-Noncommercial 4.0 Unported license. This licence allows anyone to share their work (copy, distribute, transmit) and to adapt it for non-commercial purposes provided that appropriate attribution is given, and that in the event of reuse or distribution, the terms of this license are made clear.
Authors retain copyright of their work and grant the journal right of first publication.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
